Weller, Michael; Butowski, Nicholas; Tran, David D; Recht, Lawrence D; Lim, Michael; Hirte, Hal; Ashby, Lynn; Mechtler, Laszlo; Goldlust, Samuel A; Iwamoto, Fabio; Drappatz, Jan; O'Rourke, Donald M; Wong, Mark; Hamilton, Mark G; Finocchiaro, Gaetano; Perry, James; Wick, Wolfgang; Green, Jennifer; He, Yi; Turner, Christopher D; Yellin, Michael J; Keler, Tibor; Davis, Thomas A; Stupp, Roger; Sampson, John H; ACT IV trial investigators (2017). Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncology, 18(10):1373-1385.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
Item Type: | Journal Article, refereed, further contribution |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Oncology |
Language: | English |
Date: | October 2017 |
Deposited On: | 15 Nov 2017 14:36 |
Last Modified: | 26 Jan 2022 13:56 |
Publisher: | Elsevier |
ISSN: | 1470-2045 |
OA Status: | Green |
Publisher DOI: | https://doi.org/10.1016/S1470-2045(17)30517-X |
PubMed ID: | 28844499 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-141081
Download
Links
Authors, Affiliations, Collaborations

University Hospital Zurich Neurologische Klinik, Zurich, Switzerland
University of California, San Francisco, San Francisco, United States
Washington University in St. Louis, St. Louis, United States
Stanford University Medical Center, Stanford, United States
The Johns Hopkins Hospital, Baltimore, United States
Juravinski Cancer Centre Hamilton Ontario, Hamilton, Canada
Barrow Neurological Institute, Phoenix, United States
Dent Neurologic Institute, Amherst, Amherst, United States
John Theurer Cancer Center, Hackensack, United States
Columbia University Irving Medical Center, New York, United States
University of Pittsburgh Medical Center, Pittsburgh, United States
University of Pennsylvania Perelman School of Medicine, Philadelphia, United States
Westmead Hospital, Sydney, Australia
University of Calgary, Calgary, Canada
Foundation IRCCS Neurological Institute "C. Besta", Milan, Italy
Sunnybrook Health Sciences Centre, Toronto, Canada
German Cancer Research Center, Heidelberg, Germany
Celldex Therapeutics, Inc., Needham, United States
Celldex Therapeutics, Inc., Needham, United States
Celldex Therapeutics, Inc., Needham, United States
Celldex Therapeutics, Inc., Needham, United States
Celldex Therapeutics, Inc., Needham, United States
Celldex Therapeutics, Inc., Needham, United States
University of Zurich, Zurich, Switzerland
Duke University Medical Center, Durham, United States